7 reports of this reaction
0.5% of all HYDROQUINONE reports
#74 most reported adverse reaction
MIGRAINE is the #74 most commonly reported adverse reaction for HYDROQUINONE, manufactured by Obagi Cosmeceuticals LLC. There are 7 FDA adverse event reports linking HYDROQUINONE to MIGRAINE. This represents approximately 0.5% of all 1,310 adverse event reports for this drug.
Patients taking HYDROQUINONE who experience migraine should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
MIGRAINE is a less commonly reported adverse event for HYDROQUINONE, but still significant enough to appear in the safety profile.
In addition to migraine, the following adverse reactions have been reported for HYDROQUINONE:
The following drugs have also been linked to migraine in FDA adverse event reports:
MIGRAINE has been reported as an adverse event in 7 FDA reports for HYDROQUINONE. This does not prove causation, but indicates an association observed in post-market surveillance data.
MIGRAINE accounts for approximately 0.5% of all adverse event reports for HYDROQUINONE, making it a notable side effect.
If you experience migraine while taking HYDROQUINONE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.